Novo Nordisk Foundation to Build Nvidia-Backed Ai Supercomputer

Ozempic and Wegovy, two of Denmark's most well-known drugs, have helped Novo Nordisk overtake Tesla as Europe's third-most prosperous economy, Fortune reports.

Now the Danish drugmaker is hoping to use some of the billions it's made from those two drugs to build a supercomputer that could "provide an unprecedented potential to accelerate groundbreaking scientific discoveries in areas such as drug discovery, disease diagnosis, and treatment," according to a Tuesday press release.

The Gefion supercomputer, which will be built at Denmark's national center for AI innovation, is expected to be operational by the end of the year.

The Novo Nordisk Foundation has pumped $87 million into the project, which will be available to researchers in both the public and private sectors of Denmark.

Gefion will be "one of the world's most powerful AI supercomputers," according to the press release, and will be able to answer "the queries scientists throw at it," according to Fortune.

Novo Nordisk's senior vice president says the supercomputer is "very likely" to be used by the company, which also plans to build a "mega manufacturing facility" outside Dublin to keep up with demand.

Read the Entire Article